BN 06/23 17:48 *DEMARE: PROPOSED RATIO GIVES SHRHOLDERS 30% OF SYNERGIES: FUW
BN 06/23 17:46 *DEMARE: IF NO DEAL, SHR PRICE WON'T FALL BACK TO CHF300
BN 06/23 17:45 *DEMARE: SHR PRICE PREVIOUSLY AT ABNORMALLY LOW LEVEL: FUW
BN 06/23 17:43 *SYNGENTA'S DEMARE: INVESTORS FOCUSING ON CHF449/SHR PRICE: FUW
BN 06/23 17:42 *SYNGENTA'S DEMARE: 55% OF CONTEMPLATED PRICE IN EQUITY: FUW
BN 06/23 17:41 *SYNGENTA'S DEMARE: PROPOSED TRANSACTION IS COMPLEX, RISKY: FUW
BN 06/23 17:40 *SYNGENTA'S DEMARE: WON'T REMAIN INDEPENDENT `AT ANY COST': FUW
BN 06/23 17:37 *SYNGENTA'S DEMARE REAFFIRMS REJECTION OF MONSANTO OFFER: FUW
BN 06/23 17:36 *SYNGENTA'S DEMARE COMMENTS IN INTERVIEW WITH FUW
BN 06/23 17:36 *SYNGENTA'S DEMARE SIGNALS WILLINGNESS TO NEGOTIATE: FUW
BN 06/23 17:36 *SYNGENTA'S DEMARE SAYS MONSANTO OFFER INSUFFICIENT: FUW
BN 06/23 17:46 *DEMARE: IF NO DEAL, SHR PRICE WON'T FALL BACK TO CHF300
BN 06/23 17:45 *DEMARE: SHR PRICE PREVIOUSLY AT ABNORMALLY LOW LEVEL: FUW
BN 06/23 17:43 *SYNGENTA'S DEMARE: INVESTORS FOCUSING ON CHF449/SHR PRICE: FUW
BN 06/23 17:42 *SYNGENTA'S DEMARE: 55% OF CONTEMPLATED PRICE IN EQUITY: FUW
BN 06/23 17:41 *SYNGENTA'S DEMARE: PROPOSED TRANSACTION IS COMPLEX, RISKY: FUW
BN 06/23 17:40 *SYNGENTA'S DEMARE: WON'T REMAIN INDEPENDENT `AT ANY COST': FUW
BN 06/23 17:37 *SYNGENTA'S DEMARE REAFFIRMS REJECTION OF MONSANTO OFFER: FUW
BN 06/23 17:36 *SYNGENTA'S DEMARE COMMENTS IN INTERVIEW WITH FUW
BN 06/23 17:36 *SYNGENTA'S DEMARE SIGNALS WILLINGNESS TO NEGOTIATE: FUW
BN 06/23 17:36 *SYNGENTA'S DEMARE SAYS MONSANTO OFFER INSUFFICIENT: FUW
Syngenta’s Demare Says Monsanto Offer Insufficient: FUW
2015-06-23 18:00:12.167 GMT
By Marco Bertacche
(Bloomberg) -- Syngenta’s Michel Demare reaffirms rejection
of Monsanto offer in interview with Finanz und Wirtschaft.
* Signals willingness to negotiate
* Won’t remain independent “at any cost”
* Proposed transaction is complex, risky
* Investors focusing on CHF449/shr price
* If no deal, shr price won’t fall back to CHF300
* Shr price previously at abnormally low level
* 55% of contemplated price in equity
* Proposed ratio would give Syngenta shareholders only 30% of
synergies as against 50%-70% shareholders of acquired cos.
normally get
* NOTE: Earlier, Monsanto, Syngenta Deal Likelihood Is Less
Than 60/40: Bernstein
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Marco Bertacche in Milan at +39-02-8064-4233 or
mbertacche@bloomberg.net
To contact the editors responsible for this story:
Jerrold Colten at +39-02-8064-4261 or
jcolten@bloomberg.net
James Kraus, Marco Bertacche
2015-06-23 18:00:12.167 GMT
By Marco Bertacche
(Bloomberg) -- Syngenta’s Michel Demare reaffirms rejection
of Monsanto offer in interview with Finanz und Wirtschaft.
* Signals willingness to negotiate
* Won’t remain independent “at any cost”
* Proposed transaction is complex, risky
* Investors focusing on CHF449/shr price
* If no deal, shr price won’t fall back to CHF300
* Shr price previously at abnormally low level
* 55% of contemplated price in equity
* Proposed ratio would give Syngenta shareholders only 30% of
synergies as against 50%-70% shareholders of acquired cos.
normally get
* NOTE: Earlier, Monsanto, Syngenta Deal Likelihood Is Less
Than 60/40: Bernstein
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
Marco Bertacche in Milan at +39-02-8064-4233 or
mbertacche@bloomberg.net
To contact the editors responsible for this story:
Jerrold Colten at +39-02-8064-4261 or
jcolten@bloomberg.net
James Kraus, Marco Bertacche